Dr. Prashant Shrestha, MD

Dr. Shrestha practices at M Health Fairview University of Minnesota Medical Center in Minneapolis, Minnesota, part of M Health Fairview.

Dr. Shrestha's NPI, 1457587578, was assigned on June 3, 2009. Dr. Shrestha holds Minnesota license 59259.

Dr. Shrestha's primary practice is M Health Fairview University of Minnesota Medical Center, at 2450 Riverside Avenue, Minneapolis, MN 55454 in Hennepin County. The practice phone is (612) 624-1765.

Dr. Shrestha's primary practice is M Health Fairview University of Minnesota Medical Center in Minneapolis, Minnesota, part of M Health Fairview. Dr. Shrestha is also affiliated with M Health Fairview St. John's Hospital. The medical group on file is M Health Fairview Recovery Clinic. Dmand AI also links Dr. Shrestha to 7 more group practices and clinics, 7 medical groups and 1 dialysis center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shrestha practices, 10 sites in all. Vendor and product names are available with a free account.

Vascular and interventional radiology is Dr. Shrestha's primary specialty in the NPI Registry, under taxonomy code 2085R0204X. Dr. Shrestha is licensed in Minnesota.

CMS data shows 1,435 Medicare services from Dr. Shrestha across 12 procedure codes in 2024, for 246 Medicare patients. Medicare paid $10,821 for them.

CMS counts 246 Medicare patients who saw Dr. Shrestha in 2024. The largest group is 65 to 74, with 89 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 31% are also on Medicaid. Their average risk score is 3.77, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Shrestha's median patient age at 62, with 46% women.

In 2024, Dr. Shrestha wrote 44 Medicare Part D claims for 19 patients. 95% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $115 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Shrestha for performance year 2024, reported as part of a group. Dr. Shrestha accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Shrestha as offering telehealth.

Varicose vein removal: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 10 papers to Dr. Shrestha, published from 2017 to 2023. 2017 was the busiest year, with 3. The most frequent topics are Embolization, Therapeutic, Computed Tomography Angiography and Endovascular Procedures. Dr. Shrestha has published most often in Vasc Endovascular Surg. Dr. Shrestha's most frequent co-authors are Jafar Golzarian, MD, Reza Talaie, MD and Siobhan Moira Flanagan, MD.

CMS Open Payments shows 87 general payments to Dr. Shrestha from 20 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 51% of the total. Medtronic, Inc. paid the most, $7,767.